clinical trial · NCT07039604
Real-World Study of PADN for the Treatment of PAH
Pulnovo Medical (Wuxi) Co., Ltd.·—·recruiting·n = 200
Pulmonary HypertensionHypertension, Pulmonary ArterialEnhancor™ Radiofrequency Catheter, Pulnovo Medical (Wuxi) CO., Ltd., Wuxi, Jiangsu, China
brief summary
Real-World Study of PADN for the Treatment of PAH
started
Mar 19, 2025
primary completion
Dec 30, 2028
completion
Dec 30, 2028
last updated
Jun 26, 2025
official title
Real-World Study of Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Arterial Hypertension (PAH)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol